An overview of seventeen years of experience with dothiepin in the treatment of depression in Europe

B. J. Goldstein, J. L. Claghorn

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The European clinical experience with dothiepin since 1962 indicates that it is efficacious in the treatment of depression (neurotic, psychotic, and with concomitant anxiety) in dose of 75-200 mg/day. The side effects profile is similar to the tricyclic antidepressant drugs with significantly less anticholinergic side effects and cardiotoxicity than amitriptyline. The results of the current ongoing clinical trials in the United States with several hundred patients will more precisely define the efficacy, dosage and side effect profile of dothiepin.

Original languageEnglish
Pages (from-to)64-70
Number of pages7
JournalJournal of Clinical Psychiatry
Volume41
Issue number12 II
StatePublished - Dec 1 1980
Externally publishedYes

Fingerprint

Dothiepin
Depression
Amitriptyline
Tricyclic Antidepressive Agents
Cholinergic Antagonists
Depressive Disorder
Anxiety
Clinical Trials
Therapeutics

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Clinical Psychology

Cite this

An overview of seventeen years of experience with dothiepin in the treatment of depression in Europe. / Goldstein, B. J.; Claghorn, J. L.

In: Journal of Clinical Psychiatry, Vol. 41, No. 12 II, 01.12.1980, p. 64-70.

Research output: Contribution to journalArticle

@article{7a2f345529c74059b263f672d0d21d26,
title = "An overview of seventeen years of experience with dothiepin in the treatment of depression in Europe",
abstract = "The European clinical experience with dothiepin since 1962 indicates that it is efficacious in the treatment of depression (neurotic, psychotic, and with concomitant anxiety) in dose of 75-200 mg/day. The side effects profile is similar to the tricyclic antidepressant drugs with significantly less anticholinergic side effects and cardiotoxicity than amitriptyline. The results of the current ongoing clinical trials in the United States with several hundred patients will more precisely define the efficacy, dosage and side effect profile of dothiepin.",
author = "Goldstein, {B. J.} and Claghorn, {J. L.}",
year = "1980",
month = "12",
day = "1",
language = "English",
volume = "41",
pages = "64--70",
journal = "Journal of Clinical Psychiatry",
issn = "0160-6689",
publisher = "Physicians Postgraduate Press Inc.",
number = "12 II",

}

TY - JOUR

T1 - An overview of seventeen years of experience with dothiepin in the treatment of depression in Europe

AU - Goldstein, B. J.

AU - Claghorn, J. L.

PY - 1980/12/1

Y1 - 1980/12/1

N2 - The European clinical experience with dothiepin since 1962 indicates that it is efficacious in the treatment of depression (neurotic, psychotic, and with concomitant anxiety) in dose of 75-200 mg/day. The side effects profile is similar to the tricyclic antidepressant drugs with significantly less anticholinergic side effects and cardiotoxicity than amitriptyline. The results of the current ongoing clinical trials in the United States with several hundred patients will more precisely define the efficacy, dosage and side effect profile of dothiepin.

AB - The European clinical experience with dothiepin since 1962 indicates that it is efficacious in the treatment of depression (neurotic, psychotic, and with concomitant anxiety) in dose of 75-200 mg/day. The side effects profile is similar to the tricyclic antidepressant drugs with significantly less anticholinergic side effects and cardiotoxicity than amitriptyline. The results of the current ongoing clinical trials in the United States with several hundred patients will more precisely define the efficacy, dosage and side effect profile of dothiepin.

UR - http://www.scopus.com/inward/record.url?scp=0019137807&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019137807&partnerID=8YFLogxK

M3 - Article

C2 - 7440528

AN - SCOPUS:0019137807

VL - 41

SP - 64

EP - 70

JO - Journal of Clinical Psychiatry

JF - Journal of Clinical Psychiatry

SN - 0160-6689

IS - 12 II

ER -